Cargando…
Curing Hemoglobinopathies: Challenges and Advances of Conventional and New Gene Therapy Approaches
Inherited hemoglobin disorders, including beta-thalassemia (BT) and sickle-cell disease (SCD), are the most common monogenic diseases worldwide, with a global carrier frequency of over 5%.1 With migration, they are becoming more common worldwide, making their management and care an increasing concer...
Autores principales: | Motta, Irene, Ghiaccio, Valentina, Cosentino, Andrea, Breda, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827604/ https://www.ncbi.nlm.nih.gov/pubmed/31700592 http://dx.doi.org/10.4084/MJHID.2019.067 |
Ejemplares similares
-
Gene Therapy in Thalassemia and Hemoglobinopathies
por: Breda, Laura, et al.
Publicado: (2009) -
Genome Editing for β-Hemoglobinopathies: Advances and Challenges
por: Frati, Giacomo, et al.
Publicado: (2021) -
New approaches for cholestasis in hemoglobinopathies
por: Dhiman, Pratibha, et al.
Publicado: (2015) -
Gene Therapy for Hemoglobinopathies
por: Cavazzana, Marina, et al.
Publicado: (2018) -
Gene Therapy of the Hemoglobinopathies
por: Kunz, Joachim B., et al.
Publicado: (2020)